Immunogenicity and Safety of GSK Biologicals' HBV-MPL Vaccine (2 Doses), and of Engerix™-B (3 Doses) in Healthy Adults
Clinical trial NCT00697853 · COMPLETED
Trial details
- NCT number
- NCT00697853
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 1998-11-01
- Primary completion
- 1999-07-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.